GRANT PARK VENTURES SEC REVIEW 2026
INDEPENDENT VERDICT
Grant Park Ventures has a much deeper regulatory footprint than the small headline amount in its newest SEC filing initially suggests. The latest vehicle located is Grant Park Ventures Funds LLC - Series 15, a Delaware limited liability company under SEC CIK 0002146492 that filed Form D on September 10, 2026. The filing reports a $249,991 pooled-investment-fund offering under Rule 506(b), with the entire $249,991 already sold and no amount remaining. Christopher Hanson is identified as a director, and the issuer uses 8 The Green, Suite 13283, Dover, Delaware with telephone 408-206-6612. The relatively small $249,991 amount should therefore not be interpreted as Grant Park Ventures' total assets, total venture-capital activity or platform size. It represents one specific series. Public SEC records show numerous other Grant Park Ventures Funds LLC series formed around the same platform, while older records trace Chris Hanson-linked Grant Park vehicles back years before the current numbered-series structure.
The strongest operating-company evidence comes from the firm's own website. Grant Park Ventures describes itself as an early-stage venture-capital investor backing companies across healthcare, fintech, logistics and software-enabled technology, and explains that the Grant Park name refers to Grant Park in Los Altos, California, where the founders grew up. Its public portfolio includes names such as Apptronik, Aalo, Blitzy, Lunar Outpost, Shield AI, Dyme Medical, Candosa, Otmow and Ucardia. That portfolio mix shows a materially broader strategy than a generic software seed fund: robotics, defense/autonomy, nuclear technology, lunar infrastructure, healthcare and enterprise software all appear in the visible portfolio. However, public materials do not identify which specific portfolio company or companies are economically held inside Series 15. That distinction is critical because a numbered series can represent a concentrated SPV, co-investment or a small subset of the manager's broader portfolio. Investors should therefore avoid assuming that ownership of Series 15 provides proportional exposure to every company shown on the Grant Park Ventures website.
The historical filings provide an important second layer of verification. SEC records show Grant Park Ventures Fund II LLC filing in 2018 with Chris Hanson identified in the management chain, while additional Hanson-linked GPV special-purpose vehicles appeared around the same period. More recent records reveal a rapid expansion into separately incorporated numbered series: Series 10 filed in April 2026; Series 2 filed in May; Series 8 and Series 12 filed in July; Series 1, Series 4, Series 6 and Series 9 also appear in 2026 SEC records; and Series 15 followed in September. Series 8 reported approximately $1.148 million fully sold, while Series 12 reported approximately $1.400 million fully sold. This pattern supports the interpretation that Grant Park Ventures is using legally separate series for individual investment allocations rather than raising every investment through one evergreen flagship vehicle. Researchers must therefore keep each CIK and series separate: the $249,991 in Series 15 cannot be added repeatedly to historical filings, and capital reported by Series 8, Series 12 or another numbered vehicle should not be presented as Series 15 assets.
Entity mapping requires extra caution because another, legally separate family of SEC issuers uses the phrase "a series of Grant Park Ventures, LP." Those filings use Washington addresses, list Fund GP LLC and Belltower Fund Group Ltd. as related persons, and include vehicles such as LU-0722 Fund I and NI-0225 Fund III. The currently reviewed Grant Park Ventures Funds LLC series instead use Chris Hanson, the 408-206-6612 telephone number and the Dover, Delaware address. The two families should not be merged simply because they share the words "Grant Park Ventures." There is not enough public evidence to conclude that Belltower-administered Grant Park Ventures, LP series are the same manager as Chris Hanson's Grant Park Ventures Funds LLC platform. For FilingDossier purposes, this is an unusually important separation because an automated search can easily combine unrelated CIKs, GP structures and addresses into one incorrect manager profile.
The remaining investment diligence is therefore concentrated around series-level transparency rather than basic existence. Series 15 is a real SEC-filed pooled investment vehicle with a completed $249,991 offering, and Grant Park Ventures has a visible venture-capital website, recognizable portfolio companies and a longer Hanson-linked Form D history. What public Form D data does not reveal is the specific Series 15 underlying company, acquisition price, ownership percentage, valuation, preferred-security terms, follow-on rights, management fee, carried interest, SPV administration costs, expected hold period or liquidity. Venture investors should also determine whether Series 15 owns shares directly, participates through another SPV, holds SAFEs or convertible securities, and whether the manager receives economics at both the series and underlying-fund level. The regulatory evidence verifies the offering and manager continuity; it does not establish the current value of the portfolio company, an exit timeline or future return.
SEC SNAPSHOT
LATEST FORM D: September 10, 2026 YEAR FORMED: 2025 RELATED PERSON: Christopher Hanson RELATED-PERSON ROLE: Director SECURITY TYPE: Equity FEDERAL EXEMPTION: Rule 506(b) INVESTMENT COMPANY ACT EXCLUSIONS: Sections 3(c)(1) and 3(c)(7) indicated in public filing indexes TOTAL REMAINING: $0 SALES COMMISSIONS: None identified in the public filing summary reviewed FINDERS' FEES: None identified in the public filing summary reviewed REVENUE / NAV RANGE: Declined to disclose
RECENT SERIES EVIDENCE
SERIES 2: SEC CIK 0002132902 SERIES 2 FORM D: May 1, 2026 SERIES 2 ENTITY TYPE: Delaware LLC SERIES 2 RELATED PERSON: Christopher Hanson SERIES 2 CLASSIFICATION: Venture Capital Fund / Pooled Investment Fund
SERIES 10: SEC CIK 0002130742 SERIES 10 FORM D: April 24, 2026 SERIES 10 RELATED PERSON: Christopher Hanson
SERIES 8: SEC CIK 0002135818 SERIES 8 FORM D: July 16, 2026 SERIES 8 TOTAL SOLD: Approximately $1,148,000 SERIES 8 OFFERING STATUS: Fully sold
SERIES 12: SEC CIK 0002137666 SERIES 12 FORM D: July 16, 2026 SERIES 12 TOTAL SOLD: Approximately $1,399,975 SERIES 12 OFFERING STATUS: Fully sold
SERIES 1: SEC filing located July 22, 2026 SERIES 4: SEC filing located July 22, 2026 SERIES 6: SEC filing located July 16, 2026 SERIES 9: SEC filing located July 21, 2026 SERIES 15: SEC filing located September 10, 2026
IMPORTANT CAPITAL DISTINCTION
SERIES 15 $249,991: Amount reported sold in this specific series. SERIES 15 $249,991 IS NOT: Grant Park Ventures AUM; aggregate platform capital; value of every portfolio company; current Series 15 NAV; total capital invested historically. DO NOT ADD OLD FILINGS FOR THE SAME SERIES REPEATEDLY: Each issuer and CIK must be evaluated independently. DO NOT ATTRIBUTE SERIES 8 OR SERIES 12 CAPITAL TO SERIES 15: They are separate legal issuers. DO NOT ASSUME WEBSITE PORTFOLIO EQUALS SERIES 15 PORTFOLIO: Exact underlying investment requires offering documents.
HISTORICAL MANAGER EVIDENCE
OLDER VEHICLE: Grant Park Ventures Fund II LLC FORM D YEAR: 2018 RELATED PERSON: Chris Hanson ROLE: Managing-member relationship disclosed 2018 REPORTED OFFERING CONTEXT: Small pooled-investment vehicle HISTORICAL GPV SPVS: Multiple Hanson-linked GPV vehicles also appear in prior SEC Form D indexes SIGNIFICANCE: Supports a multi-year history predating the 2025-2026 numbered-series architecture IMPORTANT: Earlier vehicles are separate legal entities and their assets should not be combined with Series 15 without specific evidence
WEBSITE / OPERATING PLATFORM
BRAND: Grant Park Ventures PUBLIC STRATEGY: Early-stage venture capital SECTORS NAMED BY FIRM: Healthcare; fintech; logistics; software; software-enabled technology BRAND ORIGIN: Grant Park in Los Altos, California PUBLIC PORTFOLIO INCLUDES: Apptronik; Aalo; Blitzy; Lunar Outpost; Shield AI; Dyme Medical; Candosa; Otmow; Ucardia EXACT SERIES 15 PORTFOLIO COMPANY: NOT PUBLICLY IDENTIFIED IN THE SOURCES REVIEWED SERIES 15 ENTRY VALUATION: NOT PUBLICLY DISCLOSED SERIES 15 OWNERSHIP PERCENTAGE: NOT PUBLICLY DISCLOSED SERIES 15 SECURITY CLASS: NOT PUBLICLY DISCLOSED BEYOND FORM D EQUITY CLASSIFICATION SERIES 15 CURRENT NAV: NOT PUBLICLY DISCLOSED SERIES 15 EXIT STATUS: NOT PUBLICLY DISCLOSED
PORTFOLIO STORY
APPTRONIK: Publicly displayed Grant Park Ventures portfolio company AALO: Publicly displayed Grant Park Ventures portfolio company BLITZY: Publicly displayed Grant Park Ventures portfolio company LUNAR OUTPOST: Publicly displayed Grant Park Ventures portfolio company SHIELD AI: Publicly displayed Grant Park Ventures portfolio company DYME MEDICAL: Publicly displayed Grant Park Ventures portfolio company CANDOSA: Publicly displayed Grant Park Ventures portfolio company OTMOW: Publicly displayed Grant Park Ventures portfolio company UCARDIA: Publicly displayed Grant Park Ventures portfolio company IMPORTANT: Website presence demonstrates manager-level investment history but does not establish which series owns each investment
ENTITY SEPARATION — CRITICAL
TARGET FAMILY: Grant Park Ventures Funds LLC numbered series KEY PERSON: Christopher / Chris Hanson PHONE: 408-206-6612 CURRENT SERIES ADDRESS: 8 The Green, Suite 13283, Dover, Delaware
SEPARATE SEC FAMILY ALSO LOCATED: Series of Grant Park Ventures, LP EXAMPLE: LU-0722 Fund I, a series of Grant Park Ventures, LP EXAMPLE: NI-0225 Fund III, a series of Grant Park Ventures, LP ADDRESS PATTERN: Seattle / Lynnwood, Washington RELATED ENTITIES: Fund GP LLC; Belltower Fund Group Ltd. PHONE PATTERN: 206-area number STATUS: DO NOT AUTOMATICALLY MERGE WITH CHRIS HANSON'S GRANT PARK VENTURES FUNDS LLC REASON: Different legal issuer architecture, addresses, related persons and contact details COMMON NAME ALONE: Insufficient evidence of common management
WEBSITE / ENTITY PENETRATION
Series 15 SEC issuer — CONFIRMED CIK 0002146492 — CONFIRMED September 10, 2026 filing — CONFIRMED $249,991 total offering — CONFIRMED $249,991 sold — CONFIRMED Rule 506(b) — CONFIRMED Christopher Hanson related-person relationship — CONFIRMED Dover address — CONFIRMED 408-206-6612 continuity across Grant Park filings — CORROBORATED Grant Park Ventures operating website — CONFIRMED Early-stage venture strategy — CONFIRMED Healthcare / fintech / logistics / software focus — CONFIRMED Public portfolio companies — CONFIRMED AT MANAGER LEVEL 2018 Grant Park Ventures Fund II filing — CONFIRMED Multiple 2026 numbered series — CONFIRMED Series 8 $1.148M — CONFIRMED Series 12 $1.399975M — CONFIRMED Exact Series 15 underlying investment — NOT PUBLICLY CONFIRMED Exact Series 15 valuation — NOT PUBLICLY CONFIRMED Current Series 15 NAV — NOT PUBLICLY CONFIRMED Series 15 fee structure — REQUIRES OFFERING DOCUMENTS Series 15 carried interest — REQUIRES OFFERING DOCUMENTS Series 15 administrator — REQUIRES OFFERING DOCUMENTS Series 15 audited financial statements — NOT LOCATED PUBLICLY Relationship to Belltower-administered Grant Park Ventures, LP — NOT ESTABLISHED
CORE INVESTOR QUESTIONS
What company or asset does Series 15 own Is Series 15 a single-company SPV or multi-company vehicle What security was purchased in the underlying company Were common shares, preferred shares, SAFEs or convertible notes acquired What was the entry valuation What price per share did Series 15 pay What ownership percentage does the series hold Does the series have pro-rata or follow-on rights Does Grant Park Ventures reserve capital for follow-on rounds Can Series 15 invest additional capital What dilution has occurred since the initial investment What is the latest underlying financing valuation Is that valuation based on an arm's-length financing round Has the investment been marked up or down since purchase What is current Series 15 NAV How is NAV calculated Who performs valuation What management fee applies What carried interest applies What SPV administration expenses apply Are organizational costs charged directly to investors Does Grant Park Ventures receive fees from the portfolio company Are there transaction or monitoring fees Can expenses be allocated across multiple Grant Park series What conflicts exist when several series invest in the same company Can one series receive different securities or terms from another What happens if additional capital is required Can investors be diluted if they do not participate What transfer restrictions apply Is there any investor liquidity before an underlying exit What happens if the portfolio company remains private for ten years or longer Who controls voting rights Can the manager sell the investment without investor consent What distribution waterfall applies after an exit What tax reporting will investors receive Who is the fund administrator Are financial statements audited What relationship, if any, exists with the separate Grant Park Ventures, LP / Belltower series family
CORE RISKS
Single-company concentration if Series 15 is an SPV; early-stage venture risk; total-loss risk; private-company valuation uncertainty; long holding periods; limited liquidity; dilution from later financing rounds; down-round risk; preferred-stock seniority risk; SAFE or convertible-security conversion risk where applicable; founder execution risk; technology obsolescence; regulatory risk affecting defense, healthcare, fintech or nuclear portfolio companies; customer concentration; capital-intensive growth risk; follow-on financing dependence; limited investor control; management-fee drag; carried-interest drag; SPV expense layering; conflicts among parallel series; portfolio-name visibility does not prove series ownership; $249,991 amount sold is not current NAV; manager-level portfolio success does not establish Series 15 performance.
PRIMARY EVIDENCE REVIEWED
U.S. Securities and Exchange Commission Grant Park Ventures Funds LLC - Series 15 CIK 0002146492 Form D September 10, 2026
U.S. Securities and Exchange Commission Grant Park Ventures Funds LLC - Series 2 CIK 0002132902 Form D May 1, 2026
U.S. Securities and Exchange Commission Grant Park Ventures Funds LLC numbered-series filings Series 1 Series 4 Series 6 Series 8 Series 9 Series 10 Series 12 2026
U.S. Securities and Exchange Commission Grant Park Ventures Fund II LLC CIK 0001755284 Form D 2018
Grant Park Ventures official website Investment strategy Brand history Public portfolio
Separate SEC records reviewed for entity differentiation: LU-0722 Fund I, a series of Grant Park Ventures, LP NI-0225 Fund III, a series of Grant Park Ventures, LP Fund GP LLC Belltower Fund Group Ltd.
IMPORTANT FORM D NOTICE
Form D is a notice of an exempt securities offering. It does not mean that the SEC approved Grant Park Ventures, Series 15, Chris Hanson, any portfolio company or the valuation used in a private transaction.
The September 10, 2026 filing establishes that Series 15 reported a $249,991 offering and reported the entire amount sold.
It does not reveal the current value of that investment or identify the underlying portfolio company in the public filing summary reviewed.
INDEPENDENT ASSESSMENT
Grant Park Ventures presents an unusual but researchable venture-capital structure.
The distinctive feature is not the small $249,991 Series 15 offering by itself.
It is the combination of a long Chris Hanson-linked SEC history, a visible early-stage operating brand, recognizable portfolio companies and a rapidly expanding family of separately incorporated numbered investment series.
That structure substantially strengthens evidence that Grant Park Ventures is operating as an active venture investor, but it also makes entity-by-entity diligence essential.
Series 15 should be evaluated as Series 15.
Its capital should not be mixed with Series 8, Series 12, Grant Park Ventures Fund II or unrelated Belltower-administered issuers that happen to use a similar Grant Park Ventures name.
The unresolved question is therefore the most important one for an investor: what exactly does Series 15 own, on what terms, at what valuation and with what fees
Form D verifies the $249,991 exempt offering.
The manager website verifies the broader venture platform.
Neither document, by itself, identifies the economic value of Series 15 today.